Ascendis_FINAL_LOGO_7.23.15.png
Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results
28. August 2019 16:01 ET | Ascendis Pharma A/S
– TransCon hGH moves towards Biologics License Application submission following completion of heiGHt and fliGHt Trials – – Global reach of endocrinology rare disease programs expands – – Conference...